Atossa Therapeutics, Inc.
SUSTAINED RELEASE COMPOSITIONS OF ENDOXIFEN

Last updated:

Abstract:

The present disclosure provides sustained release compositions of (Z)-endoxifen and polymorphs and salts thereof and methods of making sustained release compositions of (Z)-endoxifen and polymorphs and salts thereof. The present disclosure also provides methods for treating disorders susceptible to (Z)-endoxifen, including hormone dependent disorders and mood disorders.

Status:
Application
Type:

Utility

Filling date:

2 Jul 2020

Issue date:

9 Jun 2022